1248 Objectives: Radionuclide-labeled microspheres, such as Y-90 and P-32 labeled glass
microspheres have already been used for radioembolization for hepatocellular carcinoma …

Transarterial radioembolization with radionuclide‐labeled microspheres is successfully
used in hepatocellular carcinoma (HCC) treatment, but the non‐biodegradability and rapid …

Background Intrahepatic arterial injection of 90 Y glass microspheres (90 Y microspheres) is
a useful therapeutic modality for inoperative liver tumour. Recently, a new concept of …

Internal radiation therapy using intrahepatic arterial injection of 90Y-labeled glass
microspheres (90Y-microspheres) has proven to be a promising therapeutic modality for …

1461 Objectives Objective: Radionuclide-labeled microspheres have been used for
interventional radionuclide cancer therapy, but microspheres comprised of non …

1707 Objectives Selective internal radiation therapy (SIRT) involves utilization of yittrium-90
(90Y) embedded microspheres for the treatment of primary and secondary hepatic …

Radioembolisation of patients with liver carcinoma using microspheres labelled with 90Y is
increasingly being used with promising results. Although more complex than 131I-Lipiodol …

Treatment for nonresectable hepatocellular carcinoma (HCC) is palliative. The relatively
greater arteriolar density of hepatic tumors compared with normal liver suggests that …

Purpose: To investigate the antitumor effect of resin microspheres loaded with 90-yttrium
against hepatocellular carcinoma and their safety in the setting of liver cirrhosis. Patients …

1176 Objectives Y-90 resin microsphere is used to treat inoperable hepatic tumors. After
intra-arterial injection of Y-90 microsphere, evaluating the distribution of Y-90 is necessary to …